Database and biobank for patients with hypersensitivity pneumonitis
Pulmonary Fibrosis Biobank - Hypersensitivity Pneumonitis
This study is collecting blood samples and health information from people with hypersensitivity pneumonitis to see how they compare to those with idiopathic pulmonary fibrosis and to help find better ways to diagnose and understand their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Gentofte, Copenhagen Academic / other |
| Locations | 1 site (Hellerup, Copenhagen) |
| Trial ID | NCT05549635 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on collecting blood samples and clinical data from patients diagnosed with hypersensitivity pneumonitis (HP) at a multidisciplinary team conference. It is a sub-study of the Pulmonary Fibrosis Biomarker cohort, allowing for the comparison of HP patients with those suffering from idiopathic pulmonary fibrosis. The collected data will facilitate the assessment of biomarkers for diagnostic and prognostic purposes, as well as enable further subtyping of HP based on blood markers.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who have been diagnosed with hypersensitivity pneumonitis by a multidisciplinary team.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of hypersensitivity pneumonitis through improved diagnostic and prognostic biomarkers.
How similar studies have performed: Other studies have shown success in utilizing biobanks and databases for similar conditions, indicating a promising approach for this research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of HP at an MDT conference according to the current international guidelines * Age of 18 years or older * The patients must be capable of giving informed consent Exclusion Criteria: \- Unable to sign informed consent
Where this trial is running
Hellerup, Copenhagen
- Department of respiratory medicine — Hellerup, Copenhagen, Denmark (Recruiting)
Study contacts
- Study coordinator: Nils Hoyer, PhD
- Email: nils.hoyer@regionh.dk
- Phone: +45-3867 4200
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.